These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5066315)

  • 1. [Studies on the tissue distribution and the gastro-intestinal absorption of 1- -D-arabinofuranosylcytosine].
    Ono Y; Tatewaki N; Okita A; Katsura Y
    Yakugaku Zasshi; 1972 May; 92(5):592-8. PubMed ID: 5066315
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of 1-beta-D-arabinofuranosylcytosine in humans.
    Wan SH; Huffman DH; Azarnoff DL; Hoogstraten B; Larsen WE
    Cancer Res; 1974 Feb; 34(2):392-7. PubMed ID: 4521089
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical and pharmacological studies with 1-beta-D-arabinofuranosylcytosine in man.
    Creasey WA; Papac RJ; Markiw ME; Calabresi P; Welch AD
    Biochem Pharmacol; 1966 Oct; 15(10):1417-28. PubMed ID: 4291357
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical and pharmacologic studies with 1- -D-arabinofuranosylcytosine 5'-adamantoate (NSC-117614), a depot form of cytarabine.
    Neil GL; Buskirk HH; Moxley TE; Manak RC; Kuentzel SL; Bhuyan BK
    Biochem Pharmacol; 1971 Dec; 20(12):3295-308. PubMed ID: 5002403
    [No Abstract]   [Full Text] [Related]  

  • 5. Action of 1- -D-arabinofuranosylcytosine on mammalian tumor cells. 1. Incorporation into DNA.
    Zahn RK; Müller WE; Forster W; Maidhof A; Beyer R
    Eur J Cancer (1965); 1972 Aug; 8(4):391-6. PubMed ID: 4672467
    [No Abstract]   [Full Text] [Related]  

  • 6. Enzymatic estimation and metabolism of 1- -D-arabinofuranosylcytosine in man.
    Momparler RL; Labitan A; Rossi M
    Cancer Res; 1972 Feb; 32(2):408-12. PubMed ID: 4500684
    [No Abstract]   [Full Text] [Related]  

  • 7. A radioimmunoassay for 1-beta-D-arabinofuranosylcytosine.
    Okabayashi T; Mihara S; Repke DB; Moffatt JG
    Cancer Res; 1977 Feb; 37(2):619-24. PubMed ID: 832282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A radioimmunoassay method for 1-beta-D-arabinofuranosyluracil using antibodies directed against 1-beta-D-arabinofuranosylcytosine.
    Okabayashi T; Mihara S; Moffatt JG
    Cancer Res; 1977 Feb; 37(2):625-8. PubMed ID: 12864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies in mouse L-cells on the incorporation of 1-beta-D-arabinofuranosylcytosine into DNA and on inhibition of DNA polymerase by 1-beta-D-arabinofuranosylcytosine 5'-triphosphate.
    Graham FL; Whitmore GF
    Cancer Res; 1970 Nov; 30(11):2636-44. PubMed ID: 5530558
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on drug resistance. I. Distribution of l-beta-D-arabinofuranosylcytosine, cytidine and deoxycytidine in mice bearing ara-C-sensitive and-resistant P815 neoplasms.
    Uchida K; Kreis W
    Biochem Pharmacol; 1969 May; 18(5):1115-28. PubMed ID: 5789778
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism of 1-beta-D-arabinofuranosylcytosine in leukemia L1210: nucleoside and nucleotide kinases in cell-free extracts.
    Schrecker AW
    Cancer Res; 1970 Mar; 30(3):632-41. PubMed ID: 5425288
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro-in vivo correlation of drug metabolism--deamination of 1- -D-arabinofuranosylcytosine.
    Dedrick RL; Forrester DD; Ho DH
    Biochem Pharmacol; 1972 Jan; 21(1):1-16. PubMed ID: 4500983
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on drug resistance. II. Kinase patterns in P815 neoplasms sensitive and resistant to 1-beta-D-arabinofuranosylcytosine.
    Drahovsky D; Kreis W
    Biochem Pharmacol; 1970 Mar; 19(3):940-4. PubMed ID: 5534114
    [No Abstract]   [Full Text] [Related]  

  • 14. Enzyme catalyzation of the deacylation of N4-acyl derivatives of 1-beta-D-arabinofuranosylcytosine in the mouse liver microsome.
    Tsuruo T; Hori K; Iida H; Tsukagoshi S; Sakurai Y
    Cancer Res; 1982 Jun; 42(6):2250-4. PubMed ID: 7074607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological disposition and metabolic fate of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in mice and rats.
    Chou TC; Feinberg A; Grant AJ; Vidal P; Reichman U; Watanabe KA; Fox JJ; Philips FS
    Cancer Res; 1981 Sep; 41(9 Pt 1):3336-42. PubMed ID: 7260900
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolism of 1-beta-D-arabinofuranosylcytosine in L cells.
    Silagi S
    Cancer Res; 1965 Oct; 25(9):1446-53. PubMed ID: 5861073
    [No Abstract]   [Full Text] [Related]  

  • 17. The teratogenic effect of 1-beta-D-arabinofuranosylcytosine in the rat. Protection by deoxycytidine.
    Chaube S; Kreis W; Uchida K; Murphy ML
    Biochem Pharmacol; 1968 Jul; 17(7):1213-6. PubMed ID: 5659770
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement of the antiproliferative action of 1- -D-arabinofuranosylcytosine by methotrexate in murine leukemic cells (L5178Y).
    Hoovis ML; Chu MY
    Cancer Res; 1973 Mar; 33(3):521-5. PubMed ID: 4734734
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetic studies on ara-C. With special emphasis on the cellular pharmacokinetics.
    Liliemark J
    Scand J Haematol Suppl; 1986; 44():41-50. PubMed ID: 3457438
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential for selective enhancement of the in vivo metabolism of 1-beta-D-arabinofuranosylcytosine in rats by thymidine pretreatment.
    Danhauser LL; Rustum YM
    Cancer Res; 1985 May; 45(5):2002-7. PubMed ID: 3986756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.